1-deoxynojirimycin has been researched along with Thrombopenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amato, D; Patterson, MA | 1 |
| Hughes, DA; Mehta, A; Thomas, AS | 1 |
1 review(s) available for 1-deoxynojirimycin and Thrombopenia
| Article | Year |
|---|---|
Gaucher disease: haematological presentations and complications.
Topics: 1-Deoxynojirimycin; Anemia; Combined Modality Therapy; Disease Management; Enzyme Replacement Therapy; Gaucher Disease; Genetic Predisposition to Disease; Glucosylceramidase; Glycosphingolipids; Hemorrhagic Disorders; Humans; Inflammation; Lewy Body Disease; Lysosomes; Macrophage Activation; Multiple Myeloma; Parkinson Disease; Splenectomy; Splenomegaly; Thrombocytopenia; Unfolded Protein Response | 2014 |
1 other study(ies) available for 1-deoxynojirimycin and Thrombopenia
| Article | Year |
|---|---|
Combined miglustat and enzyme replacement therapy in two patients with type 1 Gaucher disease: two case reports.
Topics: 1-Deoxynojirimycin; Adult; Child, Preschool; Combined Modality Therapy; Drug Therapy, Combination; Enzyme Inhibitors; Enzyme Replacement Therapy; Female; Gaucher Disease; Glucosylceramidase; Hexosaminidases; Humans; Thrombocytopenia | 2018 |